L. Roy Papp & Associates’s Idexx Laboratories IDXX Stock Holding History

L. Roy Papp & Associates’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$300K	Hold	570	–	–	0.03%	166
2026 Q1	$320K	Hold	570	–	–	0.04%	151
2025 Q4	$386K	Hold	570	–	–	0.04%	143
2025 Q3	$364K	Hold	570	–	–	0.04%	143
2025 Q2	$306K	Sell	570 -50	-8%	-$23.9K	0.04%	152
2025 Q1	$260K	Hold	620	–	–	0.03%	156
2024 Q4	$256K	Buy	620 +150	+32%	+$65.8K	0.03%	158
2024 Q3	$237K	Hold	470	–	–	0.03%	163
2024 Q2	$229K	Hold	470	–	–	0.03%	162
2024 Q1	$254K	Hold	470	–	–	0.03%	155
2023 Q4	$261K	Hold	470	–	–	0.03%	155
2023 Q3	$206K	Hold	470	–	–	0.03%	162
2023 Q2	$236K	Sell	470 -100	-18%	-$47.9K	0.03%	161
2023 Q1	$285K	Buy	+570	New	+$273K	0.04%	149

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

L. Roy Papp & Associates's IDXX Position: Q2 2026 in Review

L. Roy Papp & Associates held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 570 shares worth $300K. The position accounts for 0.03% of the portfolio, ranked #166.

L. Roy Papp & Associates first reported a position in IDXX in Q1 2023 and has held it in 14 quarters since. The position peaked at $386K in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

L. Roy Papp & Associates held 570 shares of Idexx Laboratories worth $300K as of Q2 2026.
L. Roy Papp & Associates left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.03% of L. Roy Papp & Associates's portfolio in Q2 2026, its #166 holding.
L. Roy Papp & Associates first reported a position in Idexx Laboratories in Q1 2023 and has held it in 14 quarters since.
L. Roy Papp & Associates's Idexx Laboratories position peaked at $386K in Q4 2025.
1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on L. Roy Papp & Associates's 13F filing for Q2 2026, filed 23 Jul 2026.